These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 1635066

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo.
    Carta F, Akdemir A, Scozzafava A, Masini E, Supuran CT.
    J Med Chem; 2013 Jun 13; 56(11):4691-700. PubMed ID: 23647428
    [Abstract] [Full Text] [Related]

  • 45. Thieno[2,3-b]furan-2-sulfonamides as topical carbonic anhydrase inhibitors.
    Hartman GD, Halczenko W, Prugh JD, Smith RL, Sugrue MF, Mallorga P, Michelson SR, Randall WC, Schwam H, Sondey JM.
    J Med Chem; 1992 Aug 07; 35(16):3027-33. PubMed ID: 1501230
    [Abstract] [Full Text] [Related]

  • 46. Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties.
    Mincione F, Starnotti M, Menabuoni L, Scozzafava A, Casini A, Supuran CT.
    Bioorg Med Chem Lett; 2001 Jul 09; 11(13):1787-91. PubMed ID: 11425561
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide.
    Qian Y, Wang F, Li R, Zhang Q, Xu Q.
    Drug Dev Ind Pharm; 2010 Nov 09; 36(11):1340-7. PubMed ID: 20849349
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671,152 in glaucomatous monkeys.
    Wang RF, Serle JB, Podos SM, Sugrue MF.
    Arch Ophthalmol; 1990 Apr 09; 108(4):511-3. PubMed ID: 2322152
    [Abstract] [Full Text] [Related]

  • 51. Oculohypotensive effects of various acetozolamide nanopreparations for topical treatment of animal model-induced glaucoma and their impact on optic nerve.
    Mahmoud SS, ElAbrak ES, Aly MA, Ali EM.
    PLoS One; 2019 Apr 09; 14(2):e0212588. PubMed ID: 30789966
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. 2-Substituted 1, 3, 4-thiadiazole-5-sulfonamides as carbonic anhydrase inhibitors: their effects on the transepithelial potential difference of the isolated rabbit ciliary body and on the intraocular pressure of the living rabbit eye.
    Kishida K, Miwa Y, Iwata C.
    Exp Eye Res; 1986 Dec 09; 43(6):981-95. PubMed ID: 3817035
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans.
    Maus TL, Larsson LI, McLaren JW, Brubaker RF.
    Arch Ophthalmol; 1997 Jan 09; 115(1):45-9. PubMed ID: 9006424
    [Abstract] [Full Text] [Related]

  • 57. Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents.
    Bragagni M, Bozdag M, Carta F, Scozzafava A, Lanzi C, Masini E, Mura P, Supuran CT.
    Bioorg Med Chem; 2015 Sep 15; 23(18):6223-7. PubMed ID: 26319622
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
    Sugrue MF.
    J Ocul Pharmacol Ther; 1996 Sep 15; 12(3):363-76. PubMed ID: 8875343
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.